Europe Diabetic Retinopathy Market Growth, Trends, and Forecasts (20162021)
Europe Diabetic Retinopathy Market by Type of Treatment, By Indication, By End Users (Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (20162021)
(EMAILWIRE.COM, March 01, 2018 ) The Europe Diabetic Retinopathy Market has been estimated at USD 1.10 billion in 2016 and is projected to reach USD 1.51 billion by 2021, at a CAGR of 6.55% during the forecast period from 2016 to 2021.
Browse Full Report with TOC @ https://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/
The European diabetic retinopathy market holds the highest share in the market, driven by rising patient awareness levels, particularly in the Western European countries. Europe market is geographically segmented into Spain, Germany, Italy, UK and France.
Diabetic retinopathy is a medical condition which damages retina and leads to blindness if untreated or undiagnosed. The degree of treatment of diabetic retinopathy varies according to various stages of the disease and is mainly prioritized to curb the disease at its initial stage.
Get Free Sample Copy of Report @ https://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/request-sample
Growth enhancing factors are government initiatives, abundant R&D activities, and skill set enhancement of healthcare providers. Such supportive initiatives coupled with rising awareness among patients are anticipated to result in lucrative growth. Treatment of diabetic retinopathy is expected to gain patients willingness for treatment by introducing advanced technology and reducing pain by using laser procedure with quick recovery time.
The Europe Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of diabetic patients are predicted to propel the growth of non-proliferative diabetic retinopathy market share.
Browse Inquire before buying @ https://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/inquire
The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
Market Segmentation
By Type of Treatment
Anti-Vascular Endothelial Growth Factor (VEGF) drug
Intraocular Steroid Injection
Laser Surgery
Vitrectomy
By Indication
Non-Proliferative Diabetic Retinopathy (NPDR)
Mild
Moderate
Severe
Proliferative Diabetic Retinopathy (PDR)
By End Users
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
The scope of the report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Team Lead (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Browse Full Report with TOC @ https://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/
The European diabetic retinopathy market holds the highest share in the market, driven by rising patient awareness levels, particularly in the Western European countries. Europe market is geographically segmented into Spain, Germany, Italy, UK and France.
Diabetic retinopathy is a medical condition which damages retina and leads to blindness if untreated or undiagnosed. The degree of treatment of diabetic retinopathy varies according to various stages of the disease and is mainly prioritized to curb the disease at its initial stage.
Get Free Sample Copy of Report @ https://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/request-sample
Growth enhancing factors are government initiatives, abundant R&D activities, and skill set enhancement of healthcare providers. Such supportive initiatives coupled with rising awareness among patients are anticipated to result in lucrative growth. Treatment of diabetic retinopathy is expected to gain patients willingness for treatment by introducing advanced technology and reducing pain by using laser procedure with quick recovery time.
The Europe Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of diabetic patients are predicted to propel the growth of non-proliferative diabetic retinopathy market share.
Browse Inquire before buying @ https://www.marketdataforecast.com/market-reports/europe-diabetic-retinopathy-market-938/inquire
The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
Market Segmentation
By Type of Treatment
Anti-Vascular Endothelial Growth Factor (VEGF) drug
Intraocular Steroid Injection
Laser Surgery
Vitrectomy
By Indication
Non-Proliferative Diabetic Retinopathy (NPDR)
Mild
Moderate
Severe
Proliferative Diabetic Retinopathy (PDR)
By End Users
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
The scope of the report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Team Lead (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results